Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care Novo Nordisk manufactures and markets pharmaceutical products and services. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk employs more than 40,000 people globally, and markets its products in 180 countries. Our key contribution is to discover and develop better biological medicines, manufacture them to meet increasing global demand and make them accessible wherever they are needed. We are committed to finding the next generation of medicines and long-term investments in innovation have made us experts in the field of modern biotechnology.
Novo Nordisk In IRANNovo Nordisk largest pharmaceutical company in Denmark, and one of the 10 largest drug manufacturer in the world was founded in 1923. Novo Nordisk has more than 90 years of innovation and leadership in diabetes care in its resume. This heritage has given to Novo Nordisk experience and capabilities that also enable it to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 41,000 people in 75 countries and markets its products in more than 180 countries. Novo Nordisk's reputation in Iran and the Middle East is unexampled and that’s because of Novo Nordisk's presence in IRAN and all Middle Eastern countries. Right now, Novo Nordisk is looking for top-of-the class graduates for the Novo Nordisk Finance Graduate Programme to start in September 2016. After finishing the programme students will take up a permanent position in IRAN as e.g. finance or project analyst, finance controller, internal consultant, specialist or similar. For 20 years, Novo Nordisk has been present in IRAN and in 2005 founded its agency in IRAN. In September 2015, Iran's Ministry of Health and Novo Nordisk signed a contract to build a factory to generate new generation of insulin for Diabetics. After finishing this factory IRAN would be top 5 of countries which make new generation of insulin in the world.
- Location Denmark
- Listing categories HEALTHCARE